Nebracetam is an investigational drug of the racetam family that is a M1 acetylcholine receptor agonist in rats.
[1] Based on a human leukemic T cell experiment in 1991, it is believed to act as an agonist for human M1-muscarinic receptors.
[2] It is also believed to act as a nootropic, like many other racetam drugs.
[3] A chemoenzymatic method of synthesis was reported in 2008.
This drug article relating to the nervous system is a stub.